Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Decibel Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 39 | 42 | +3 |
| Shares | 17.7M | 17.9M | +178.0K (+1.0%) |
| Value | $53.8M | $75.2M | +$21.4M (+39.9%) |
New holders (10)
Institutions that held Decibel Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Newtyn Management, LLC | 310,000 | $1.30M | 0.25% |
| EAM Investors, LLC | 254,981 | $1.07M | 0.26% |
| ExodusPoint Capital Management, LP | 225,000 | $947.0K | 0.01% |
| UBS Oconnor LLC | 87,745 | $369.0K | 0.00% |
| Two Sigma Securities, LLC | 17,683 | $74.0K | 0.01% |
| Spire Wealth Management | 16,600 | $70.0K | 0.00% |
| CSS LLC | 10,800 | $45.0K | 0.00% |
| UBS Group AG | 1,504 | $6.00K | 0.00% |
| Simplex Trading, LLC | 1,102 | $4.00K | 0.00% |
| Wells Fargo & Company | 48 | $0 | 0.00% |
Sold out (7)
Institutions that held Decibel Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Casdin Capital, LLC | 330,000 | $1.00M |
| Woodline Partners LP | 275,001 | $836.0K |
| Suvretta Capital Management, LLC | 263,600 | $801.0K |
| Two Sigma Investments, LP | 22,308 | $68.0K |
| Bailard, Inc. | 19,700 | $60.0K |
| Susquehanna International Group, LLP | 16,846 | $51.0K |
| FNY Investment Advisers, LLC | 3,200 | $9.00K |